4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001682068-26-000003
CHIEF FINANCIAL OFFICER sold 4,739 shares at $16.35 ($77,483)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Regnante Keith CHIEF FINANCIAL OFFICER | 2026-02-18 | Sale | −4,739 | $16.35 | $77,483 | 39,261 | D |
| Open-market sales · 4,739 sh · avg $16.35 · $77,483 | |||||||
Loading xslF345X05/form4-02202026_040201.xml…